Aguilar-Cordova Estuardo (CIK 0001873919)

Latest company ownership

Shares held
14,240
Last filed at
Jun 29, 2023
Confidence Score
49.5
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 21, 2025 Feb 25, 2025 Candel Therapeutics, Inc. 10% Owner Sell 37.5 -21,165 -0.48% ✗ $254.4K
Feb 10, 2025 Feb 13, 2025 Candel Therapeutics, Inc. 10% Owner Sell 30.0 -31,335 -0.73% ✗ $269.8K
Dec 26, 2024 Dec 30, 2024 Candel Therapeutics, Inc. 10% Owner Sell 17.5 -200,000 -4.35% ✗ $1.8M
Dec 20, 2024 Dec 26, 2024 Candel Therapeutics, Inc. 10% Owner Sell 17.5 -300,000 -5.37% ✗ $2.7M
Dec 11, 2024 Dec 13, 2024 Candel Therapeutics, Inc. 10% Owner Sell 16.3 -800,000 -13.81% ✗ $7.4M
Dec 4, 2024 Dec 6, 2024 Candel Therapeutics, Inc. 10% Owner Sell 20.0 -60,000 -1.18% ✗ $289.6K
Nov 25, 2024 Nov 27, 2024 Candel Therapeutics, Inc. 10% Owner Sell 40.0 -20,000 -0.39% ✗ $99.4K
Nov 6, 2024 Nov 8, 2024 Candel Therapeutics, Inc. 10% Owner Sell 32.5 -45,000 -0.77% ✗ $231.6K
Oct 30, 2024 Nov 1, 2024 Candel Therapeutics, Inc. 10% Owner Sell 32.5 -42,000 -0.71% ✗ $223.1K
Oct 24, 2024 Oct 28, 2024 Candel Therapeutics, Inc. 10% Owner Sell 32.5 -30,929 -0.53% ✗ $172.3K
Oct 11, 2024 Oct 15, 2024 Candel Therapeutics, Inc. 10% Owner Sell 32.5 -40,412 -0.68% ✗ $243.8K
Oct 1, 2024 Oct 3, 2024 Candel Therapeutics, Inc. 10% Owner Sell 40.0 -22,574 -0.38% ✗ $155.5K
May 6, 2022 May 10, 2022 Candel Therapeutics, Inc. Director Sell 22.5 -54,074 -1.68% ✗ $197.4K